APPLICATION
ANDA212169
TYPE
ANDA
ORIGINAL APPROVAL
2022-03-02
LATEST ACTION
2023-02-14
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
EFINACONAZOLEDiscontinued
EFINACONAZOLE 10% · SOLUTION · TOPICAL
Approval history
2023-02-14Labeling · Supplement 1 · standardAP
2022-03-02UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.